Nevro (NVRO) Tops Q4 EPS by 12c, Offers FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. DOX
8. INSP
9. HNGE
10. AMD

Go back to Nevro (NVRO) Tops Q4 EPS by 12c, Offers FY Guidance

Nevro Reports Fourth Quarter and Full Year 2020 Financial Results

February 24, 2021 4:05 PM EST

REDWOOD CITY, Calif., Feb. 24, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full year ended December 31, 2020 and provided 2021 guidance.

Recent Highlights

Fourth Quarter 2020 Worldwide Revenue of $109.7 Million; Decrease of 4% Compared to Prior Year Fourth Quarter 2020 Net Loss from Operations of $0.9 Million; Fourth Quarter 2020 Non-GAAP Adjusted EBITDA of $15.7 Million Company Provides Full-Year 2021 Revenue Guidance of $430 Million to $450 Million Company... More